Abstract PS08-09: Impact of HER2 expression dynamics on the real-world activity of trastuzumab deruxtecan for metastatic breast cancer (RELIEVE)Paolo Tarantino, Sara M. Tolaney, Heather Moore et al.|Cancer Research|2024Cited by 11
Abstract 5257: Durable clinical and radiographic responses in a series of patients with HER2+ Breast Cancer (BC) Leptomeningeal Disease (LMD) treated with trastuzumab deruxtecan (T-DXd)Laura Alder, Sarah Sammons, Dario Trapani et al.|Cancer Research|2022Cited by 5
52. BrMPANEL: A PUBLIC RESOURCE OF ORGANOTROPIC CELL LINESManuel Valiente, Frank Winkler, Amanda Van Swearingen et al.|Neuro-Oncology Advances|2020Cited by 0